RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jonathan Hickson

Family Medicine · Livingston, LANPI 1285021881

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,190, more than ten times the $21 reported in 2020.

$1,527in general payments, 2019–2025

Across 99 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$275
  • Vanda Pharmaceuticals Inc.$218
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$152
  • Lilly USA, LLC$92
  • GSK$77
  • AstraZeneca$77
  • plus $636 from 16 others

What the payments were for

  • Food & beverage$1,527100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie19$275
Vanda Pharmaceuticals Inc.12$218
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)19$152
Lilly USA, LLC5$92
GSK4$77
AstraZeneca5$77
Lundbeck LLC3$64
Corium, LLC6$63
Abbott2$59
Boehringer Ingelheim3$56
Amgen3$51
Dexcom, Inc.2$45
Axsome Therapeutics, Inc.2$37
Optinose US, Inc.2$37
Alkermes, Inc.2$35
Phathom Pharmaceuticals, Inc.2$35
Idorsia Pharmaceuticals US Inc2$33
Novo Nordisk2$32
Otsuka America Pharmaceutical, Inc.1$28
Johnson & Johnson1$21
Genentech USA, Inc.1$21
Exact Sciences1$19

How this compares

$1,527 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$27,287
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,920
Gabapentin25$770
Duloxetine Hcl15$689
Atorvastatin Calcium63$590
Fluticasone Propionate23$403
Metformin Hcl ErMetformin Hcl30$264
Pantoprazole Sodium24$191
Citalopram HbrCitalopram Hydrobromide11$162
Sumatriptan Succinate11$152
Metoprolol Succinate12$142
Valsartan14$117
Lisinopril13$89
Tamsulosin Hcl16$63
Hydrochlorothiazide12$48

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$56$27,28726 claims
GSKTrelegy Ellipta$77$13,92017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Livingston

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →